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Background: Nonalcoholic fatty liver disease (NAFLD) is a risk factor for hepatocellular carcinoma (HCC), but the
association between a high-fat diet (HFD) and HCC is not fully understood. In this study, we investigated whether a
high-saturate-fat diet affects hepatocarcinogenesis induced by administration of diethylnitrosamine (DEN).
Methods: Adult SD rats were randomized into the following groups: normal chow diet (NCD), HFD, NCD + DEN,
and HFD + DEN. The HFD contains 2% cholesterol and 10% lard oil. In mice with DEN treatment, the carcinogen
was given via gavage. Mice were sacrificed at the end of 10, 12, and 14 weeks, respectively. The effects of HFD on
hepatic carcinogenesis were assessed by HCC incidence, tumor differentiation, and the number and size of tumor
nodules. Western blot and immunohistochemistry for proliferating cell nuclear antigen (PCNA), enzyme-linked
immunosorbent assay (ELISA) for caspase-3, and real-time PCR for TNF-α and IL-6 further uncovered the proliferative
and apoptotic properties of liver.
Results: In contrast to the NCD group, DEN treatment (NCD + DEN group) led to hepatitis, cirrhosis, hepatic tumor,
and decreased body weight. Interestingly, HFD, which induced hyperlipidemia and hepatic steatosis, attenuated
DEN-related malnutrition and fibrosis progression in HFD + DEN group during 10–14 weeks. Moreover, the HFD +
DEN group exhibited that the proportion of well differentiated HCC was much higher than that of NCD + DEN
group. The number and average volume of HCC node were also significantly lowered in HFD + DEN group
(P < 0.01-0.05). When compared to that of NCD + DEN group, there was an inhibited expression of PCNA, TNF-α,
and IL-6, and activation of caspase-3 in the liver of HFD + DEN group at week 10 and 12.
Conclusions: HFD restores malnutrition in the DEN-treated rats, which in turn inhibits the initiation of hepatic
carcinogenesis and malignancy.
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Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer and the third leading cause of cancer-related
mortality worldwide [1,2]. HCC has clearly defined etio-
logical factors such as chronic hepatitis B (CHB), chronic
hepatitis C (CHC), long-term heavy alcohol consumption,
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unless otherwise stated.malnutrition and obesity [3,4]. Clinical epidemiological and
animal studies have shown that high-fat diets (HFD) with
high-calorie intake significantly contribute to the develop-
ment of obesity and NASH [5-9]. As HFD can induce lipid
peroxidation and contribute to DNA damage, it is consid-
ered a risk factor for HCC [10-15].
However, some recent studies have interestingly sug-
gested that HFD could delay the development of can-
cers in several organs such as breast, prostate, and liver
[14-19]. Dietary intake of polyunsaturated fatty acid
(PUFA)-enriched fish oil has been reported to limit
post-operative metastasis and increase recurrence-free
survival in melanoma-bearing rodents [14]. To furthertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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shown that n-3 PUFA supplements possess anti-
tumorigenic and anti-migratory abilities in breast and
prostate cancers [15-17]. Similarly, C57BL/6 DIO mice
receiving fat forage demonstrate decreased HCC inci-
dence and diminished area of hepatic foci [18]. HFD
(contains 13.6-23.5% fat) inhibits the density, average
area, and unit area of HCC foci in F344 rats [19].
To clarify the role of HFD during hepatocarcinogenen-
sis, we have established an animal model of HCC using
the classic hepatic carcinogen diethylinitrosamine (DEN)
in rats chronically fed high-saturate-fat diet to experi-
mentally recapitulate the development of liver cancer in
the setting of fatty liver disease, and to understand the
possible mechanisms therein.
Methods
Animals and experimental procedures
Adult male Sprague–Dawley rats (10 weeks old, average
body weight 98.7 ± 6.3 g) (B&K Universal Group Ltd,
Shanghai, China) were bred in a specific pathogen free
animal unit of Shanghai Xinhua Hospital. Rats were ran-
domized into four groups each treated with or without
DEN (given diethylinitrosamine 10 mg/kg/d by gavage)
[20]. Animals were housed in plastic cages in groups of five
and permitted ad libitum consumption of water and diet.
Rats were allowed to acclimatize for a week on the normal
chow diet (NCD) before grouping. Rats were given HFD
(10% lard oil, 2% cholesterol, and 88% normal chow diet)
[7] with or without DEN from week 2, and were closely
monitored for physical abnormalities and were sacrificed at
the end of weeks 10, 12, and 14. Serum samples were col-
lected via cardiac puncture and maintained at −20°C until
further analysis. Liver was quickly removed and weighted.
Part of the liver tissues was snap frozen in liquid nitrogen
for further analysis. Two small pieces (1 × 1 × 0.5 cm [3]) of
liver tissues were immediately fixed in 10% neutral-buffered
formalin for histological analysis. All animal studies were
approved by the Shanghai Jiao Tong University Institutional
Animal Care and Use Committee.
Serum lipid profile and liver function tests
Serum level of total cholesterol (TC), triglyceride (TG),
high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), and albumin was mea-
sured by using a commercial kit (Wako Pure Chemical
Industries, Richmond, VA, USA). Serum level of alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) was measured using multichannel automatic analyzer
(Bayer Advia 1650, Leverkusen, Germany).
Histologic analysis
Rat liver tissues were embedded in paraffin, and then cut
into 4 μm thickness sections. Slides were subjected toroutine hematoxylin-eosin (H&E) staining and Van-
Greson (VG) staining. Liver fibrosis was graded according
to the Metavir Score system, and chronic hepatitis activity
index (HAI) proposed by Knodell was adopted to calculate
the liver inflammatory activity score [21]. HAI = P + L +
2 × (PN + BN). P represents periportal inflammation, L
represents lobular inflammation, PN represents piecemeal
necrosis, and BN represents bridging and multi-lobular
necrosis. Development of HCC was studied by two inde-
pendent pathologists who were blind to the study.
Measurement of cell proliferation and apoptosis
The ability of hepatocytes to undergo apoptosis in re-
sponse to the above-mentioned treatment regimens was
examined by measuring the expression levels of active form
of Caspase 3 in liver tissues using commercial enzyme-
linked immunosorbent assay (ELISA) kits (XiTang Biothch
Inc., Shanghai, China) according to the manufacturer’s
instructions.
Measurement of PCNA by Western blot: Total hepatic
protein was prepared and quantified by the bicinchoni-
nic acid method (Pierce, Rockford, IL, USA). Thirty mi-
crograms of protein per sample was loaded onto a 10%
SDS polyacrylamide gel. After electrophoresis, the pro-
tein was transferred onto a polyvinylidenedifluoride
membrane (PVDF) (Millipore, Billerica, MA, USA). The
membrane was incubated with anti-PCNA antibody
(1:1500, Epitomics, USA) for overnight at 4°C and then
with HRP-conjugated goat anti-mouse IgG (1:4000; Jackson
ImmunoResearch Laboratories Inc, West Grove, PA, USA)
for 2 h at room temperature. Following three washes with
TBST, the signal on the membrane was developed by
using SuperSignal West Pico Chemiluminescent Substrate
(Pierce, Rockford, USA). β-actin was used as a loading
control (Santa Cruz, Santa Cruz, CA, USA) (1:500).
Measurement of PCNA by immunohistochemistry:
Sections (5 μm thick) were cut from formalin-fixed
and paraffin embedded liver samples. After a standard
dehydration-rehydration procedure, liver sections were
incubated with 3% H2O2 for 10 min to quench en-
dogenous peroxidase activity. The sections were then
heated using a steamer for 20 min in 10 mM sodium
citrate (pH 6.0) buffer to retrieve antigen. The routine
biotin-streptavidin immunohistochemical method con-
sisted of sequential incubations in goat serum blocking
solution, monoclonal anti-PCNA (1:100, Epitomics,
USA) biotinylated goat anti-rabbit IgG. The liver speci-
mens were finally treated with diaminobenzidine sub-
strate and then counterstained with hematoxylin.
Real-time PCR
RNA isolation and purification: Total RNA was isolated
from frozen liver tissues using Trizol reagent. (1) Reverse
transcription: cDNA was synthesized from the isolated
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Kit (Fermentas, Lithuania). (3) Real-time PCR: Gene-
specific primer sequences were designed using the Primer
Premier 5.0 software and custom-synthesized by Shanghai
Sangon Biological Engineering Technology and Service
Co. Ltd. (China). Glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) gene was used as an internal control.





TNF-α: sense 5′-CTTCTGCCTGCTCTTTGGA 3′,
anti-sense 5′-AGGAACAGCTGGCTGCCTGTCT 3′.
The PCR reaction was carried out in each well using
20 μL reaction mixture containing 10 μL SYBR Premix
Ex Taq, 0.4 μL primer mix (including forward and re-
verse primers) and 1 μL cDNA diluted in Rnase-free
water. The ΔΔCT method was used for relative quantifi-
cation of the results.
Statistics
Data were expressed as mean ± standard deviation (SD).
SPSS 16.0 statistical package was used to conduct the stat-
istic analysis. One way ANOVA was used for comparing
the grading scores of different groups, and Fisher’s exact
test was used for rate comparison. A P value of less than
0.05 (two-tailed) was considered statistically significant.
Results
Effect of HFD and DEN on nutrition status
In rats fed NCD, administration of DEN (i.e., NCD+DEN
group) led to a significant weight loss and a marked de-
crease in BMI at weeks 10, 12, and 14 (P < 0.01, compared
to the NCD alone group, Table 1). In sharp contrast, when
the rats fed on HFD were exposed to DEN (i.e., HFD +
DEN group) for the same duration, there was a less reduc-
tion in body weight and BMI (P < 0.01, Table 1). Despite
the improved nutritional indexes, body weight, body
length and BMI of the HFD +DEN group were still lower
than those of the HFD group (P < 0.01, Table 1).
High-saturate-fat diet improved liver function test in
DEN-treated rats
As shown in Table 1, NCD fed rats displayed a signifi-
cant elevation in serum ALT and AST following DEN
treatment (i.e., the NCD +DEN group vs the NCD along
group). Simultaneous treatment with HFD and DEN
(the HFD +DEN group), however, dramatically reduced
the AST level at the end of 14 weeks (P <0.01 compared
to the NCD +DEN group, Table 1). In parallel, there was
an increased serum concentration of ALB in the HFD +DEN group at the weeks 10 to 14 (P < 0.05 compared to
the NCD +DEN group, Table 1).
High-saturate-fat diet induced hyperlipidemia and hepatic
steatosis
Compared to rats in the NCD +DEN group, rats in the
HFD +DEN group demonstrated significant elevation of
serum TC and LDL-C (Table 1). In contrast, there was
no significant difference in serum level of TG between
the NCD +DEN and the HFD +DEN groups.
In accordance with the above changes, HFD fed rats
(including the HFD and HFD +DEN groups) displayed
moderate to severe hepatic steatosis, hepatocyte balloon-
ing, and infiltration of lymphocytes and mononuclear
cells within lobule and portal area (Figure 1). In contrast,
the livers in the rats of the NCD +DEN group showed
moderate to severe hepatic necroinflammation without
or only with mild steatosis.
High-saturate-fat diet delayed DEN-related liver fibrosis
and HCC
Subsequent pathological disorders, including hepatic
necroinflammation, nodular regeneration, liver fibrosis/
cirrhosis, dysplasia and HCC could be observed in rats
with DEN administration (Figures 1 and 2). No rats de-
veloped obvious pathological changes in the NCD group.
In the HFD group, Grade 1 liver fibrosis was observed in
12.5% of rats by week 12 and 25% by week 14. When the
NCD fed rats were given DEN (i.e., NCD +DEN group),
all rats developed Grade 4 fibrosis by weeks 10–14. In
contrast, in the HFD +DEN group, there was a delayed
fibrogenesis in the liver with slightly reduced HAI
(Table 2), in that Grade 4 fibrosis only developed in
57.1% of rats by week 10, 71.4% by week 12, and 90% by
week 14 (Table 2).
Following DEN exposure, there was a marked increase
in the incidence of hepatic tumors, most of which were
HCC, with the only one case of mixed HCC and cholan-
giocarcinoma in the NCD +DEN group at week 12.
Compared to the NCD +DEN group, rats in HFD +
DEN group developed less hepatic tumor nodules by
weeks 10 (0% vs 42.9%) and week 12 (28.6% vs 71.4%).
Further analysis revealed that rats in the HFD + DEN
group developed less number of the tumor nodules
compared to rats in the NCD +DEN group by week 14
(Table 3), and the number of rats with large nodules
(≥5 mm) was smaller in the HFD +DEN group com-
pared to the NCD +DEN group (P < 0.05) (Table 3). The
average volume of tumor nodules was also significantly
smaller in the HFD + DEN group than in the NCD +
DEN group (p < 0.01) (Table 3). Additionally, the hepatic
tumours in the HFD +DEN group were generally better
differentiated than tumours in the NCD +DEN group at
week 14 (Table 3).
Table 1 Effect of high-saturate-fat diet and DEN on nutrition status, serum lipid profile and liver function test










ALT (U/L) AST (U/L) ALB (g/L)
10 NCD 8 379.00 ± 27.83 24.13 ± 0.64 0.62 ± 0.05 1.47 ± 0.17 0.17 ± 0.05 1.01 ± 0.13 0.89 ± 0.09 42.38 ± 7.76 133.75 ± 22.30 35.24 ± 1.13
HFD 8 486.88 ± 34.50 26.55 ± 0.69 0.66 ± 0.03 2.13 ± 0.50 0.38 ± 0.34 1.45 ± 0.25# 1.39 ± 0.36# 48.38 ± 14.29 172.63 ± 59.49 36.18 ± 2.20
NCD +
DEN





25.14 ± 0.75▲▲ 0.57 ± 0.03▲▲$$ 4.05 ± 1.41▲ 0.54 ± 0.22 2.27 ± 0.48▲▲** 2.51 ± 1.00▲** 144.90 ±
22.83**$$
187.74 ± 17.89 38.96 ±
1.29▲*$
12 NCD 8 429.50 ± 19.32 25.81 ± 0.70 0.65 ± 0.03 1.58 ± 0.14 0.35 ± 0.15 1.13 ± 0.15 1.02 ± 0.10 36.63 ± 18.12 131.75 ± 28.74 37.25 ± 2.31





23.71 ± 2.06 0.51 ± 0.04^^&& 2.55 ± 0.40^ 0.46 ± 0.13 1.32 ± 0.15 1.54 ± 0.18^ 118.64 ± 20.55^^ 258.71 ± 48.22^^ 34.57 ± 3.31
HFD +
DEN
7 384.3 ± 28.9▲▲$$ 25.43 ± 0.53 0.59 ± 0.04▲▲$$ 4.64 ± 0.79▲▲** 0.59 ± 0.14*$ 2.77 ± 0.23▲▲** 2.88 ± 0.56▲▲** 149.69 ± 35.13** 272.72 ± 102.56** 38.90 ± 1.17▲
14 NCD 8 442.20 ± 49.66 26.00 ± 0.91 0.66 ± 0.08 1.75 ± 0.16 0.28 ± 0.18 1.12 ± 0.16 1.09 ± 0.10 53.00 ± 9.62 148.56 ± 27.05 37.15 ± 1.71










25.75 ± 0.98▲▲ 0.58 ± 0.04▲▲$$ 4.85 ± 0.95▲▲**$$ 0.56 ± 0.20* 2.65 ± 0.25▲▲**$ 3.04 ± 0.69▲▲** 151.86 ± 23.54** 248.90 ± 68.52▲▲* 40.00 ±
1.96▲*$
NCD: normal chow diet; HFD: high saturate fat diet; DEN: diethylinitrosamine; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ALT, alanine
aminotransferase; AST, aspartate aminotransferase; ALB, albumin.
HFD + DEN vs NCD + DEN: ▲P < 0.05, ▲▲P < 0.01; HFD + DEN vs NCD: *P < 0.05, **P < 0.01; HFD + DEN vs HFD: $P < 0.05, $$P < 0.01; NCD + DEN vs NCD: ^P < 0.05, ^^P < 0.01; NCD + DEN vs HFD: &P < 0.05, &&P < 0.01; HFD



















Figure 1 Histological features by H&E and VG staining. Liver tissues of H&E staining displayed the well differentiated HCC (A, 10w) and
middle differentiated HCC (B, 12w) in DEN + CD group, hepatic steatosis (C, 10w) and well differentiated HCC with steatosis (D, 12w) in DEN +
HFD group. Then H&E staining was performed in liver tissues of NCD (E, n = 8), HFD (F, n = 8), NCD + DEN (G, n = 9), and HFD + DEN (H, n = 10)
groups after 14 weeks. Liver tissues of VG staining were obtained from rats fed on NCD (I, n = 8), HFD (J, n = 8), NCD + DEN (K, n = 7), and HFD +
DEN (L, n = 7) for 10 weeks. Magnification: ×200.
Figure 2 Gross specimen of rat liver. Liver specimen from NCD (A, 14 weeks (n = 8) ), HFD (B, 14 weeks (n = 8)), NCD + DEN (C, 10 weeks
(n = 7); E, 12 weeks (n = 7); G, 14 weeks (n = 9)) and HFD + DEN groups (D, 10 weeks (n = 7); F, 12 weeks (n = 7); H, 14 weeks (n = 10)) displays the
effect of DEN and/or HFD on carcinogenesis.
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Table 2 High-saturate-fat diet delayed DEN-related liver fibrosis
Week Group n HAI Liver fibrosis
0 (%) 1 (%) 2 (%) 3 (%) 4 (%)
10 NCD 8 0 8 (100) 0 (0) 0 (0) 0 (0) 0 (0)
HFD 8 2.5 ± 1.0 8 (100) 0 (0) 0 (0) 0 (0) 0 (0)
NCD + DEN 7 12.1 ± 2.2 0 (0) 0 (0) 0 (0) 0 (0) 7 (100)
HFD + DEN 7 10.7 ± 2.9 0 (0) 0 (0) 1 (14.3) 2 (28.6) 4 (57.1)
12 NCD 8 0 8 (100) 0 (0) 0 (0) 0 (0) 0 (0)
HFD 8 3.1 ± 1.2 7 (87.5) 1 (12.5) 0 (0) 0 (0) 0 (0)
NCD + DEN 7 14.9 ± 4.5 0 (0) 0 (0) 0 (0) 0 (0) 7 (100)
HFD + DEN 7 11.0 ± 1.2 0 (0) 0 (0) 0 (0) 2 (28.6) 5 (71.4)
14 NCD 8 0 8 (0) 0 (0) 0 (0) 0 (0) 0 (0)
HFD 8 3.6 ± 1.9 6 (75.0) 2 (25.0) 0 (0) 0 (0) 0 (0)
NCD + DEN 9 15.1 ± 3.1 0 (0) 0 (0) 0 (0) 0 (0) 9 (100)
HFD + DEN 10 14.0 ± 2.3 0 (0) 0 (0) 0 (0) 1 (10) 9 (90)
NCD, normal chow diet; HFD, high saturate fat diet; DEN, diethylinitrosamine; HAI, hepatitis activity index.
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As demonstrated by Western blot, the expression level
of PCNA in the liver at week 14 was similar between the
NCD +DEN group and the HFD +DEN group. However,
there was a more significant reduction in the PCNA ex-
pression in HFD +DEN group by weeks 10 and 12 com-
pared to rats in the NCD +DEN group of the same
respective time points (Figure 3A). The effect of HFD on
HCC proliferation was further confirmed by immunohis-
tochemically staining for PCNA. As compared to that in
the DEN +NCD group (10 week: 55.71 ± 8.28 cells/field;
12 week: 56.57 ± 10.26 cells/field; 14 week: 62.11 ± 8.45
cells/field), PCNA-positive HCC cells in the DEN +HFD
group were much less (10 week: 34.29 ± 5.94 cells/field;
12 week: 41.14 ± 7.06 cells/field; 14 week: 60.50 ± 11.68
cells/field) at the time points of 10 and 12 week (P <
0.05, Figure 3B).
We also measured the hepatic content of Caspase-3 as
a marker of apoptosis by ELISA. At weeks 10 and 12,
there was a significantly increase in the hepatic level of
Caspase-3 in the HFD +DEN group compared to the
NCD+DEN group (P < 0.05). However, the hepatic
Caspase-3 content of the DEN +HFD group was signifi-
cantly lower than that of the DEN+NCD group at the
time point of 14 week (P <0.05) (Figure 4).Table 3 High-saturate-fat diet delayed DEN-induced HCC form
Group Differentiation Total no. of
tumour noduleHigh Low
NCD + DEN 1 8 15.33 ± 6.32
HFD + DEN 4 6 7.80 ± 4.37**
NCD: normal chow diet; HFD: high saturate fat diet; DEN: diethylinitrosamine.
HFD + DEN vs NCD + DEN: *P < 0.05, **P < 0.01.Effect of HFD on TNF-α and IL-6 expression
When compared to that of NCD group, rats of the DEN +
NCD group were suffered from the significant increase
of TNF-α and IL-6 mRNA levels in the liver at time
points of 10, 12, and 14 week (P < 0.05, Figure 3C-D).
Contrastively, translational level of these inflammatory
cytokines experienced statistical inhibition after the ex-
posure to HFD (DEN +HFD group vs DEN + NCD
group, P < 0.05, Figure 3C-D).
Discussion
Malnutrition and ensuing weigh loss reflect the most
common complications of cancer patients and also asso-
ciated with some malignant tumor [22-24]. In response
to elevated energy consumption in cancer patients, more
calories than normal are needed to maintain the nutri-
tion status and organ function [22]. Recently study has
revealed that low-fat intake could lead to the deterior-
ation of energy status in HCC patients, and this was as-
sociated with a poor recovery from invasive treatments
[25]. Consistently, a fat-enriched artificial liquid diet (20
non-protein kcal/kg per day) has been reported to re-
store the weight loss in patients with gastrointestinal
carcinomas [23]. HFD with ketogenic regimen, in which
up to 80% of the energy is supplied by medium chaination (week 14)
s/rat
No. of rats with
tumour nodules ≥5 mm
Average tumour
nodules (mm3)
2.33 ± 1.32 3196.86 ± 7772.85
1.20 ± 0.79* 513.34 ± 1132.90**
Figure 3 HFD reduces the hepatic expression of PCNA, TNF-α, and IL-6. (A, B) Hepatic expression of PCNA by Western blot (A) and
immunohistochemistry (B). Compared to rats from NCD + DEN group (10w: n = 7, 12w: n = 7, 14w: n = 9), rats from the HFD + DEN group
(10w: n = 7, 12w: n = 7, 14w: n = 10) exhibited marked decrease in the expression of PCNA, particularly at weeks 10 and 12. Arrows indicate the
liver cells positive for PCNA. Magnification: ×400. Hepatic expression of TNF-α (C), and IL-6 (D) by real-time PCR. *P <0.05.
Figure 4 HFD predisposes rat to hepatic apoptosis. Hepatic level
of caspase-3 was determined by ELISA. Increased hepatic level of
caspase-3 was found in the HFD + DEN group (10w: n = 7, 12w:
n = 7, 14w: n = 10) than in the NCD + DEN groups (10w: n = 7, 12w:
n = 7, 14w: n = 9). *: P <0.05.
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mice with colon adenocarcinoma [24]. HFD, therefore, is
suggested to normalize the nutrition status against
cancer-related cachexia.
In our animal study, we observed that rats treated with
NCD+DEN exhibited weight loss, delayed growth, de-
creased BMI, and a derangement of liver function. In con-
trast, rats treated with HFD+DEN showed increased body
weight, body length and BMI. This nutritional improve-
ment was accompanied by partial improvement of serum
aminotransferases and albumin. Additionally, in HFD fed
rats, there was an increased serum level of TC, LDL-C and
HDL-C. Thus, HFD may be protective against DEN-related
malnutrition and liver dysfunction test.
Recent studies have indicated that nutrition status, as
defined by such parameters as serum TC, HDL-C, and
LDL-C, has profound impact on the initiation and pro-
gression of hepatic carcinogenesis [18,19]. There is a sig-
nificant inverse correlation between serum HDL-C level
and the risk of cancer, which is independent of age, sex,
BMI, diabetes, LDL-C, and smoking history [26]. On the
other hand, HCC patients show lower levels of serum
TC, HDL-C, LDL-C, and triglycerides compared to
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of LDL-C even serves as a significant and independent
predictor of HCC in patients with CHB or CHC [29-31].
Additionally, high serum level of TC was negatively as-
sociated with the development of liver cancer in both
sexes [32].
Similar results could be observed in our experiments
that the incidence rate of HCC was lower in the HFD +
DEN group, which was characterized by increased serum
levels of TC, HDL-C and LDL-C, in comparison with
that of the DEN +NCD group at weeks 10 and 12. After-
ward, all rats of both the NCD +DEN group and the
HFD +DEN group developed HCC at week 14. However,
the total number of tumour nodules, the proportion of
large tumour nodules (≥5 mm), and the average volume
of tumour nodules were significantly less in the HFD +
DEN group than those in the NCD +DEN group. Fur-
thermore, the tumours in the HFD +DEN group showed
better differentiation status than those in the NCD +
DEN group. Therefore, HFD appeared to attenuate the
occurrence of HCC and malignant differentiation in rat
HCC model induced by DEN.
Although saturated fatty acid and unsaturated fatty acids
share the nutritional role in tumour-bearing animals, they
differ from each other in their roles in carcinogenesis
[14,15,19,33]. In a DEN-related rodent model of HCC,
high-saturated-fat diet (containing 48% of calories as palm
oil) but not the high-polyunsaturated-fat diet (containing
48% of calories as safflower oil) reduced the occurrence of
γ-glutamyl transpeptidase-positive and ATPase-negative
foci in the liver [33]. When compared to those in corn-oil-
diet treated rats, the density, average area and unit area of
HCC foci are also inhibited in the male Fischer 344 rats
after their exposure to 13.6% and 23.5% lard diets [34]. In
consistent to the short-term effect of fatty acids, 100% of
mice with a diet of high polyunsaturated-to-saturated fatty
acid (P/S) ratio develop lymphoma at 12 to 14 months. In
contrast, only 70% of mice fed low P/S diet developed
lymphoma [19]. Thus, saturated fatty acid, but not unsat-
urated fatty acids, might be able to inhibit the initiation of
carcinogenesis.
Treatment of DEN usually gives rise to stepwise histo-
logical appearances of hepatitis, liver fibrosis, cirrhosis,
hepatocellular adenoma and HCC [35-38]. However,
combination of high-saturated-fat diet and DEN seemed
to ameliorate hepatic necroinflammation and liver fibro-
genesis with reduced serum aminotransperases in this
study. As compared to the rats in the NCD +DEN
group, rats in the HFD +DEN group showed a delayed
progression in liver fibrosis and cirrhosis with reduced
HAI at the end of 10, 12, and even 14 weeks.
The impact of HFD on the development of liver fibro-
sis and HCC formation may be related to the inhibitory
effect of HFD on cell proliferation and induction ofapoptosis [15,39]. In vitro studies have shown that chol-
esterol deficiency in the culture medium could promote
the neoplastic cellular growth [40,41]. In our study, rats
in the HFD +DEN group exhibited significantly reduced
proliferation of hepatocytes (expression of hepatic PCNA
by Western blot and immunohistochemistry) than those
in the NCD+DEN group at the end of 10 and 12 weeks.
These data support an inhibitory role of high-saturated-fat
and 2% cholesterol diet in the initiation of HCC. However,
there is no significant difference of hepatocytes prolifera-
tion between the DEN +HFD group and DEN+NCD
group after 14 weeks.
Resistance to apoptosis represents a fundamental
feature of HCC. Activation of hepatic caspase-3, which
serves as an indispensible executor of apoptosis pathway
[42], was found to be more prominent in the rats of the
HFD +DEN group than in the NCD+DEN group, indi-
cating a more active apoptotic state in rats of the HFD +
DEN group. Activation of caspase-3 would in turn activate
the mitochondrial apoptosis pathway and predispose HCC
to programmed cell death [43,44]. An inhibitory effect
on the production of hepatic TNF-α and IL-6, which take
the critical place in carcinogenesis [45], may shed light on
the mechanisms of HFD treatment that delays the DEN-
induced HCC in its early stage.
Our study has a few limitations. First, we did not
include rats fed HFD with similar daily calorie intake to
the NCD group in this study. Thus we could not defin-
itely conclusive that HFD inhibits the initiation of DEN-
induced hepatocarcinogenesis, and the effect of HFD in
this study might partly depend on total calorie intake ra-
ther than fat intake.
Conclusions
Long-term high-saturated-fat diet with increased total
calorie intake facilitates the normalization of the DEN-
induced malnutrition in SD rats. This nutritional im-
provement attenuates histological activity of necroin-
flammatory and liver fibrosis progression. Moreover, it
causes lower number and average volume of HCC node
in the rats as compared to the control, possibly through
the anti-proliferative and pro-apoptotic effect of HFD.
High-saturate fat diet and high calorie intake, therefore,
may serve as an inhibitor of the initiation of hepatic car-
cinogenesis and malignant progression in a rat DEN model.
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